News

MassDevice1d
Medtronic submits Hugo surgical robot to FDA, meets trial endpoints
Medtronic (NYSE:MDT) announced today that it recently submitted its Hugo surgical robot platform to the FDA for a urologic ...
Are robots going to replace human surgeons soon? Here's what Musk predicts
Medtronic, an Ireland-based healthcare company that develops medical technology, recently experimented with its Hugo robot, ...
Medtronic plc: Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo robotic-assisted surgery system
Largest multi-center prospective Investigational Device Exemption (IDE) study for multi-port robotic-assisted urologic ...
Cancer Therapy Advisor2d
RAPN and OPN Produce Similar Outcomes in Patients With Renal Tumors
Patients with intermediate- or high-complexity renal tumors generally have similar outcomes with RAPN and OPN, data suggest.
Le Lézard3d
Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugotm robotic-assisted surgery system
Medtronic , a global leader in healthcare technology, today announced that the Expand URO Investigational Device Exemption ...
Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system
Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced that the Expand URO Investigational Device ...